JANET BROOM: Open Payments
NPI 1740297498 · SALEM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,829 in 108 payments from 23 companies in 2025. Trend: 2023 $1,145 · 2024 $1,300 · 2025 $1,829
Food & beverage: $1,829
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $319 |
| Novo Nordisk Inc | 18 | $284 |
| AstraZeneca Pharmaceuticals LP | 10 | $167 |
| Lilly USA, LLC | 11 | $163 |
| Janssen Pharmaceuticals, Inc | 6 | $145 |
| ABBVIE INC. | 13 | $139 |
| Alkermes, Inc. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Viatris Specialty LLC | 4 | $71 |
| Collegium Pharmaceutical, Inc. | 4 | $59 |
Products named: CAPLYTA, SPRAVATO, MOUNJARO, BREZTRI, ARISTADA, VRAYLAR, YUPELRI, JARDIANCE.
Industry payments across IL — which companies pay providers there.
